Insider Transactions in Q4 2020 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+25.82%
|
$9,000
$1.4 P/Share
|
|
Dec 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,203
-100.0%
|
$205,075
$25.6 P/Share
|
|
Dec 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,203
+50.0%
|
$32,812
$4.84 P/Share
|
|
Dec 14
2020
|
David M Mott Director |
BUY
Other acquisition or disposition
|
Indirect |
1,582
+7.78%
|
-
|
|
Dec 01
2020
|
David M Mott Director |
BUY
Other acquisition or disposition
|
Indirect |
1,613
+9.38%
|
-
|
|
Nov 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
8,203
-100.0%
|
$188,669
$23.05 P/Share
|
|
Nov 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,203
+50.0%
|
$32,812
$4.84 P/Share
|
|
Nov 09
2020
|
David M Mott Director |
BUY
Other acquisition or disposition
|
Indirect |
1,608
+11.69%
|
-
|
|
Oct 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
4,101
-10.84%
|
$69,717
$17.5 P/Share
|
|
Oct 21
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,101
+9.78%
|
$16,404
$4.84 P/Share
|
|
Oct 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,953
+49.37%
|
$83,812
$4.63 P/Share
|
|
Oct 20
2020
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
4,102
-100.0%
|
$65,632
$16.74 P/Share
|